Markovits Stock DeMarco

Free Case Evaluation. Call 855-843-5442.

  • Home
  • Attorneys
    • Bill Markovits
    • Christopher D. Stock
    • Paul M. De Marco
    • Terence R. Coates
    • Dylan Gould
    • Jonathan T. Deters
    • Spencer Campbell
    • Isabel DeMarco
    • Pierre Bergeron
    • Justin C. Walker
    • James Smith
  • Practice Areas
    • Class Action
    • Personal Injury
    • Product Liability
    • Sports & Entertainment Law
    • Securities Litigation
    • Commercial Litigation
    • Data Breach
    • Arbitration
  • Local Counsel
  • Case Results
  • Blog
  • Contact
  • Home
  • Attorneys
    • Bill Markovits
    • Christopher D. Stock
    • Paul M. De Marco
    • Terence R. Coates
    • Dylan Gould
    • Jonathan T. Deters
    • Spencer Campbell
    • Isabel DeMarco
    • Pierre Bergeron
    • Justin C. Walker
    • James Smith
  • Practice Areas
    • Class Action
    • Personal Injury
    • Product Liability
    • Sports & Entertainment Law
    • Securities Litigation
    • Commercial Litigation
    • Data Breach
    • Arbitration
  • Local Counsel
  • Case Results
  • Blog
  • Contact
Markovits Stock DeMarco

Over $2 Billion Recovered For Clients

Medtronic Diabetes Data Breach Class Action Investigation

On Behalf of Markovits, Stock & DeMarco, LLC | Apr 19, 2023 | Class Action

Markovits, Stock & DeMarco, LLC, a law firm experienced in data breach and Meta pixel class action litigation, is investigating claims on behalf of victims of a data breach involving data entrusted to Medtronic Minimed, Inc. and Medtronic Distribution Corp. (aka Medtronic Diabetes) through their InPen™ Diabetes Management iOS and Android mobile applications (the “InPen App”). If you received a data breach notification from Medtronic Diabetes, please contact us as soon as possible to understand your legal rights in response to the data breach.

Medtronic Diabetes is a medical device manufacturing company headquartered in Minneapolis, MN, which sells a variety of insulin delivery systems to patients suffering from diabetes, with an annual revenue of $570 million. It is a subsidiary of Medtronic in Ireland, with global revenue of $31.5 billion. [1]

What Happened?

On April 14, 2023, Medtronic Diabetes reported that it had discovered that several Google Services tracking and authentication technologies used by the company had disclosed certain information about users through the company’s InPen App to Google without the users’ permission, through February 13, 2023. Medtronic Diabetes revealed the InPen App had used Google Analytics for Firebase (“Google Analytics”), Crashlytics for Firebase (“Crashlytics”) and Firebase Authentication (collectively “Google Services”), which had gathered and sent personal identifying information and protected health information to Google.[2]

What Data is Involved in the Medtronic Diabetes Data Breach?

  • Name
  • E-mail address
  • IP Address
  • Phone number
  • InPen App user name and password
  • Certain unique identifiers tied to your InPen account or mobile device [3]

What Should I do if I Received Notification of the Data Breach from Medtronic Diabetes?

If you would like to have a free, confidential consultation with an attorney to learn more about your rights and potential legal remedies related to the Medtronic Diabetes data security breach, please contact Markovits, Stock & DeMarco attorney Terry Coates at (513) 651-3700, email us at [email protected], or submit a Case Evaluation request through the form below.

[1] https://www.jdsupra.com/legalnews/medtronic-minimed-inc-and-minimed-4006570/

[2] https://dojmt.gov/wp-content/uploads/Consumer-notification-letter-156.pdf

[3] https://www.jdsupra.com/legalnews/medtronic-minimed-inc-and-minimed-4006570/

Recent Posts

  • Ingram Micro Data Breach Class Action Investigation
  • AIS InfoSource LP Data Breach Class Action Investigation
  • HEXPOL Data Breach Class Action Investigation
  • Fitzgerald Wealth Management, LLC Data Breach Class Action Investigation
  • Benjamin Wealth Group Data Breach Class Action Investigation

Archives

Categories

  • Class Action
  • Firm News

RSS Feed

Subscribe To This Blog’s Feed

Markovits Stock & DeMarco

119 E. Court Street
Suite 530
Cincinnati, Ohio 45202
Cincinnati Office

855-843-5442

855-843-5442

Get Social

Follow us on social media, or leave a review.

  • Follow
  • Follow
  • Follow
Review Us

Get A Free Case Evaluation

We welcome the opportunity to learn about your legal case. We offer consultations in person, by phone and by videoconference. Learn more about what our lawyers can do for you.

© 2025 Markovits, Stock & DeMarco, LLC • All Rights Reserved

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw

 855-843-5442

 EMAIL